-
公开(公告)号:US20070060641A1
公开(公告)日:2007-03-15
申请号:US10557268
申请日:2004-05-18
申请人: Tatsuji Enoki , Eiji Kobayashi , Kinuko Ogawa , Yoko Kudo , Masashige Tanabe , Hiromu Ohnogi , Hiroaki Sagawa , Ikunoshin Kato
发明人: Tatsuji Enoki , Eiji Kobayashi , Kinuko Ogawa , Yoko Kudo , Masashige Tanabe , Hiromu Ohnogi , Hiroaki Sagawa , Ikunoshin Kato
IPC分类号: A61K31/343 , A61K31/225 , A61K31/19 , A61K31/192 , A61K31/11
摘要: The present invention relates to a therapeutic agent or prophylactic agent for a disease accompanying an abnormality in an amount of insulin or insulin response, an insulin-mimetic action agent, a food, beverage, or feed, an agent for enhancement of glucose uptake into a cell, and an agent for inducing differentiation into an adipocyte, each comprising as an effective ingredient at least one compound selected from the group consisting of specified compounds having an insulin-mimetic action, derivatives thereof, and pharmacologically acceptable salts thereof.
摘要翻译: 本发明涉及一种伴随胰岛素或胰岛素反应量异常的疾病的治疗剂或预防剂,胰岛素模拟作用剂,食物,饮料或饲料,用于增强葡萄糖摄入 细胞和用于诱导分化成脂肪细胞的药剂,其各自包含至少一种选自具有胰岛素模拟作用的特定化合物,其衍生物和其药理学上可接受的盐的至少一种化合物作为有效成分。
-
公开(公告)号:US20090076136A1
公开(公告)日:2009-03-19
申请号:US12263809
申请日:2008-11-03
申请人: Tatsuji ENOKI , Eiji Kobayashi , Kinuko Ogawa , Yoko Kudo , Masashige Tanabe , Hiromu Ohnogi , Hiroaki Sagawa , Ikunoshin Kato
发明人: Tatsuji ENOKI , Eiji Kobayashi , Kinuko Ogawa , Yoko Kudo , Masashige Tanabe , Hiromu Ohnogi , Hiroaki Sagawa , Ikunoshin Kato
IPC分类号: A61K31/343 , A61K31/225 , A61K31/19 , A61K31/192 , A61K31/11 , A61P3/04 , A61P3/10
摘要: The present invention relates to a therapeutic agent or prophylactic agent for a disease accompanying an abnormality in an amount of insulin or insulin response, an insulin-mimetic action agent, a food, beverage, or feed, an agent for enhancement of glucose uptake into a cell, and an agent for inducing differentiation into an adipocyte, each comprising as an effective ingredient at least one compound selected from the group consisting of specified compounds having an insulin-mimetic action, derivatives thereof, and pharmacologically acceptable salts thereof.
摘要翻译: 本发明涉及一种伴随胰岛素或胰岛素反应量异常的疾病的治疗剂或预防剂,胰岛素模拟作用剂,食物,饮料或饲料,用于增强葡萄糖摄入 细胞和用于诱导分化成脂肪细胞的药剂,其各自包含至少一种选自具有胰岛素模拟作用的特定化合物,其衍生物和其药理学上可接受的盐的至少一种化合物作为有效成分。
-
公开(公告)号:US20070092551A1
公开(公告)日:2007-04-26
申请号:US10555017
申请日:2004-04-30
申请人: Tatsuji Enoki , Eiji Kobayashi , Kinuko Ogawa , Yoko Kudo , Masashige Tanabe , Hiromu Ohnogi , Hiroaki Sagawa , Ikunoshin Kato
发明人: Tatsuji Enoki , Eiji Kobayashi , Kinuko Ogawa , Yoko Kudo , Masashige Tanabe , Hiromu Ohnogi , Hiroaki Sagawa , Ikunoshin Kato
IPC分类号: A61K31/7048 , A61K31/353 , A61K31/12 , A61K47/00
CPC分类号: A61K31/365 , A23K20/111 , A23K20/116 , A23L33/10 , A61K31/121 , A61K31/222 , A61K31/341 , A61K31/343 , A61K31/351 , A61K31/352 , A61K31/366 , A61K31/381 , C07C49/84 , C07C69/017 , C07D307/46
摘要: A therapeutic agent and prophylactic agent for a disease accompanying an abnormality in an amount of insulin or insulin response, an agent for an insulin-mimetic action, a food, beverage and feed, an agent for enhancing glucose uptake into a cell, and an agent for inducing differentiation into an adipocyte, characterized in that each comprises as an effective ingredient at least one compound selected from the group consisting of a chalcone compound, an acetophenone compound, a coumarin compound, a phthalide compound, derivatives thereof, and pharmacologically acceptable salts thereof.
摘要翻译: 用于伴随胰岛素或胰岛素反应量异常的疾病的治疗剂和预防剂,胰岛素模拟作用剂,食品,饮料和饲料,用于增强葡萄糖摄入细胞的药剂和药剂 用于诱导分化为脂肪细胞的方法,其特征在于,每种包含作为有效成分的至少一种选自查耳酮化合物,苯乙酮化合物,香豆素化合物,苯酞化合物,其衍生物和其药理学上可接受的盐的化合物 。
-
公开(公告)号:US20060216362A1
公开(公告)日:2006-09-28
申请号:US10557184
申请日:2004-05-14
申请人: Tatsuji Enoki , Kinuko Ogawa , Hiromu Ohnogi , Nobuko Muraki , Yoko Kudo , Hiroaki Sagawa , Ikunoshin Kato
发明人: Tatsuji Enoki , Kinuko Ogawa , Hiromu Ohnogi , Nobuko Muraki , Yoko Kudo , Hiroaki Sagawa , Ikunoshin Kato
IPC分类号: A61K36/9066 , A61K36/886 , A61K36/282 , A61K36/28 , A61K36/704 , A61K36/185
CPC分类号: A61K36/896 , A23K20/10 , A23L33/105 , A61K36/185 , A61K36/28 , A61K36/282 , A61K36/287 , A61K36/70 , A61K36/704 , A61K36/886 , A61K36/906 , A61K36/9066
摘要: The present invention relates to a therapeutic agent and prophylactic agent for a disease accompanying an abnormality in an amount of insulin or insulin response, an agent for an insulin-mimetic action, a food, beverage and feed for treating a preventing a disease accompanying an abnormality in an amount of insulin or insulin response, an agent for enhancing glucose uptake into a cell, and an agent for inducing differentiation into an adipocyte, characterized in that each comprises as an effective ingredient a processed product derived from at least one plant selected from the group consisting of (a) a plant belonging to Tiliaceae, (b) a plant belonging to Zingiberaceae, (c) a plant belonging to Compositae, (d) a plant belonging to Liliaceae, and (e) a plant belonging to Polygonaceae.
摘要翻译: 本发明涉及一种伴随胰岛素或胰岛素反应量异常的疾病的治疗剂和预防剂,用于胰岛素模拟作用的药物,用于治疗预防伴随异常的疾病的食品,饮料和饲料 一定量的胰岛素或胰岛素反应,用于增强葡萄糖摄入细胞的药剂和用于诱导分化成脂肪细胞的药剂,其特征在于每种药物包含作为有效成分的来自至少一种选自以下的植物的加工产品: (a)属于尖嘴科的植物,(b)属于姜科的植物,(c)属于菊科的植物,(d)属于百合科的植物,和(e)属于Poly科的植物。
-
公开(公告)号:US20090292012A1
公开(公告)日:2009-11-26
申请号:US11795806
申请日:2006-01-26
申请人: Tatsuji Enoki , Yoko Kudo , Katsumi Sugiyama , Hiromu Ohnogi , Hiroaki Sagawa , Ikunoshin Kato
发明人: Tatsuji Enoki , Yoko Kudo , Katsumi Sugiyama , Hiromu Ohnogi , Hiroaki Sagawa , Ikunoshin Kato
IPC分类号: A61K31/366 , A61K36/23 , C07D493/04
CPC分类号: A61K31/366 , C07D493/04
摘要: A therapeutic agent or prophylactic agent for a disease requiring an anti-foaming action for a cell and/or an inhibitory action for acyl-CoA cholesterol acyltransferase in treatment or prevention, characterized in that the therapeutic agent or prophylactic agent comprises as an effective ingredient a processed product derived from Peucedanum japonicum.
摘要翻译: 用于需要治疗或预防的酰基辅酶A胆固醇酰基转移酶的细胞需要消泡作用的疾病和/或抑制作用的治疗剂或预防剂,其特征在于所述治疗剂或预防剂包含作为有效成分的 来自日本蒲苇的加工产品。
-
公开(公告)号:US20100317613A1
公开(公告)日:2010-12-16
申请号:US12445784
申请日:2007-10-11
申请人: Hiromu Ohnogi , Yoko Kudo , Hiroko Nakahara , Tatsuji Enoki , Ikunoshin Kato
发明人: Hiromu Ohnogi , Yoko Kudo , Hiroko Nakahara , Tatsuji Enoki , Ikunoshin Kato
IPC分类号: A61K31/715 , A61P25/00
CPC分类号: A61K31/729 , A23K20/121 , A23L33/105 , A61K31/351 , A61K31/7016 , A61K31/702
摘要: It is intended to provide a drug, a food or a feed which has an effect of enhancing the activity of a second-phase detoxifying enzyme and an effect of increasing intracellular glutathione content.
摘要翻译: 旨在提供具有增强第二阶段解毒酶的活性和增加细胞内谷胱甘肽含量的作用的药物,食物或饲料。
-
-
-
-
-